Treatment Outcomes in Stage III Colon Cancer Appear Better in Aspirin, COX-2 Inhibitor Users

According to the results of a study recently reported in the Journal of the National Cancer Institute, patients with stage III colon cancer who take aspirin or other agents that inhibit cyclooxygenase-2 near the time of adjuvant chemotherapy appear to hav [...]

XBiotech Launches Website and Call Center to Facilitate Recruitment for U.S. Phase III Study of Xilonix™ in Metastatic Colorectal Cancer

AUSTIN, Texas, March 12, 2015—XBiotech announced today that it has launched a website and call center to help patients with metastatic colorectal cancer learn about its U.S. Pivotal Phase III clinical trial. The Phase III study named, XilonixTM  Colore [...]

Predicting SIR-Spheres® microspheres Treatment Outcomes for Metastatic Colorectal Cancer

Pre-treatment laboratory tests may play a key role in predicting patient outcomes prior to selective internal radiation therapy for metastatic colorectal cancer, while a new modeling technology for enhancing delivery of treatment could improve treatment s [...]

Oncotype DX Changes Treatment Recommendations in Stage II Colon Cancer

Use of the Oncotype DX® colon cancer test changed treatment recommendations in 29 percent of stage II colon cancer patients, according to the results of a study published in Current Medical Research and Opinion. Stage II colon cancer refers to … Continue reading

High Blood Sugar May Increase Risk of Colorectal Cancer

In a study of postmenopausal women, those with higher blood sugar were more likely than those with lower blood sugar to develop colorectal cancer. These results were published in the British Journal of Cancer. Colorectal cancer is the second leading cause of cancer death in the United States. The disease strikes both men and women, […]

Confirmation that Oncotype DX Colon Cancer Test Predicts Recurrence Risk

Among patients with Stage II colon cancer, use of the Oncotype DX colon cancer test provides information about risk of cancer recurrence and may help guide treatment decisions. These results were published in the Journal of Clinical Oncology. Gene expression profiling explores the patterns of genes that are active in tumor cells. Studies suggest that […]

CancerConnect Live Web Chat with Dr. Howard Hochster on Advances in Treatment Decision Making for Patients with Early-Stage Colon Cancer on Tuesday, November 8, 2011 at 6:00 PM Eastern Time

Advances in Treatment Decision Making for Patients with Early-Stage Colon Cancer- Live Web Chat with Howard Hochster, MD Dr. Howard Hochster is a Professor of Medicine at Yale School of Medicine (Medical Oncology), the Associate Cancer Center Director for Clinical Research at Yale Cancer Center and the Director of the GI Oncology Program. Click here for […]

CancerConnect Live Web Chat with Dr. Sidransky on Picking the Cancer Treatment That Works Best for You on Wednesday, November 2, 2011 at 6:00 PM Eastern Time

Picking the Cancer Treatment That Works Best for You- Ask the Expert about Personalized Medicine Live Web Chat with David Sidransky, MD, Johns Hopkins Medicine, Baltimore, MD, click here for bio Dr. David Sidransky is an award-winning oncologist and a world leading authority in the field of molecular diagnostics, targeted therapies and individualized patient treatments. […]

Diabetes May Increase Colorectal Cancer Risk

A combined analysis of previous studies provides additional evidence that people with diabetes may be at increased risk of colon cancer and rectal cancer. These results were published in the American Journal of Gastroenterology. Diabetes affects almost 26 million people in the United States and is the seventh leading cause of death.[1] Diabetes contributes to […]

Men May Benefit from Earlier Screening for Colorectal Cancer

A study in Austria suggests that men tend to develop advanced adenomas (colon polyps that may become cancerous) at an earlier age than women, and may benefit from earlier colorectal cancer screening. These results were published in the Journal of the American Medical Association. Colorectal cancer is the second leading cause of cancer death in […]